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Abstract: When a biomaterial is inserted into the body, proteins rapidly adsorb onto its surface,
creating a conditioning protein film that functions as a link between the implant and adhering
cells. Depending on the nano-roughness of the surface, proteins will adsorb in different amounts,
with different conformations and orientations, possibly affecting the subsequent attachment of cells
to the surface. Thus, modifications of the surface nanotopography of an implant may prevent
biomaterial-associated infections. Fibrinogen is of particular importance since it contains adhesion
epitopes that are recognized by both eukaryotic and prokaryotic cells, and can therefore influence
the adhesion of bacteria. The aim of this study was to model adsorption of fibrinogen to smooth
or nanostructured silica surfaces in an attempt to further understand how surface nanotopography
may affect the orientation of the adsorbed fibrinogen molecule. We used a coarse-grained model,
where the main body of fibrinogen (visible in the crystal structure) was modeled as rigid and the flexible
αC-chains (not visible in the crystal structure) were modeled as completely disordered. We found that the
elongated fibrinogen molecule preferably adsorbs in such a way that it protrudes further into solution on a
nanostructured surface compared to a flat one. This implicates that the orientation on the flat surface
increases its bio-availability.
Keywords: protein adsorption; coarse-grained modeling; fibrinogen; nanoparticles; nanotopography
1. Introduction
When a biomaterial is inserted into the body, a protein film consisting of plasma proteins from
the blood is immediately formed on the implant surface. The 340 kDa glycoprotein fibrinogen is an
abundant protein in the blood of vertebrates and is primarily involved in blood clotting and readily
adsorbs to biomaterial surfaces upon implantation. In a wound, thrombin polymerizes fibrinogen
into fibrin that, together with platelets, form a clot over the wound. When adsorbed to the surface of
a biomaterial, fibrinogen can trigger inflammatory responses and subsequent formation of a fibrous
capsule that can lead to failure or loss of function of the biomaterial. The fibrinogen molecule
harbors epitopes that are recognized by both human and bacterial cells through specific integrins [1–4].
An infection on an implant can have severe consequences and is one of the most common causes
of implant failure and need for revision surgery. Surface modifications at the nanoscale have
previously been suggested as a promising approach to prevent adhesion of bacteria and development of
biomaterial-associated infections on implants [5]. A leading cause for biomaterial-associated infections
is the bacterium Staphylococcus epidermidis [6], which is normally present on human skin. A recent
study found that the ability of S. epidermidis to adhere on adsorbed fibrinogen is highly dependent on
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the nanostructure of the underlying substrate, possibly by affecting the orientation or conformation of
the adsorbed fibrinogen molecule [7].
In the present study, we used coarse-grained Monte Carlo simulations to investigate how
fibrinogen adsorbs to smooth and nanostructured surfaces (with attached nanoparticles). This enabled
us to analyze in more detail how fibrinogen adsorbs and explain the experimental findings described
above. We investigated the effect of surface charge, the effect of nanoparticle size, the angles between
bound fibrinogen and the surface, and the effect of the disordered fragments (the αC-chains) of
fibrinogen.
Human fibrinogen consists of two symmetrical halves that each contain three polypeptide chains
called Aα (610 amino acid residues), Bβ (461 amino acid residues), and γ (411 amino acid residues).
The chains are connected to each other by several disulfide bonds. Fibrinogen folds into a 45-nm-long
rod with two thicker nodules (the D domains) at the ends, and one nodule in the middle of the rod
(the E domain). The C-terminal 410 amino acid residues of the Aα-chains are not visible in the crystal
structure [8] and are here counted as the disordered αC-chains, which extend out from the two D
domains (sometimes only the C-terminal 400 residues are included). NMR studies have shown that
the αC-regions of bovine fibrinogen each contain a structured domain of approximately 60 amino
acid residues [9]. However, the stability of this structure is low. Human fibrinogen seems to have
αC-domains with similar structure but even less stable than the bovine ones [10].
In one of the simplest models that has been used for simulations of fibrinogen, the protein is
approximated as an elongated ellipsoid [11] (see Figure 1a). In another study of fibrinogen adsorption,
the protein was described as three connected squares [12] (see Figure 1b). Zhdanov et al. described
fibrinogen as a linear pentamer with a monomer diameter of 7.5 nm [13] (see Figure 1c). A somewhat
more detailed model that has been used to describe fibrinogen in simulations is a linear chain consisting
of 23 touching spheres of different diameters, mimicking the differences in thickness at different parts
of the fibrinogen rod [14,15] (see Figure 1d). The spheres at the ends had a diameter of 6.7 nm, the one
in the middle 5.3 nm, and the remaining ones 1.5 nm. This model was later extended by adding two
side arms representing the αC-chains [16] (see Figure 1f). The side arms were also linear but the angle
φ between the side arms and the body of the protein was varied.
Atomistic molecular dynamics simulations of the main body of fibrinogen (excluding the
αC-chains and other flexible parts not visible in the crystal structure) in solution have also been
performed, revealing bending motions of the protein [17]. An atomistic representation of the fibrinogen
crystal structure is shown in Figure 1h. The simulations showed that two hinges are responsible for
the flexibility of the protein while the rest of the fibrinogen main body does not undergo large
conformational changes. Based on these results, a simplified coarse-grained model of fibrinogen was
developed (see Figure 1e). In that model, fibrinogen is represented by a stiff central rod connected to
two other rods that can pivot around the hinges. The ends of the protein and the central domain are
represented as spheres.
The atomistic simulations of fibrinogen in solution were followed by a study of fibrinogen
adsorption on mica and graphite, where one half of the symmetric fibrinogen rod was modeled
atomistically [18]. The binding of fibrinogen to gold nanoparticles has been studied using a
coarse-grained model where fibrinogen was modeled from the crystal structure determined by Kollman
et al. [8] and each amino acid residue was represented as a sphere (see Figure 1g). The amino acids
interacted via a bonded potential (a sum of potentials for bonds, angles and dihedrals) and a nonbonded
potential (two Lennard-Jones-type potentials—one local and one nonlocal) [19].
We used the model depicted in Figure 1g, where each amino acid of the crystal structure is
coarse-grained into a sphere. However, we considered the molecule as completely rigid and thus the
spheres did not move relative to each other. Such a model was also used by Lopez and Lobaskin [20].
This model has an intermediate level of detail and takes the charge distribution over the molecule into
account. This enables us to study the electrostatic effects behind the adsorption of fibrinogen.
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Figure 1. Depiction of models that have been used for simulations of fibrinogen with increasing level
of detail: (a) ellipsoid model [11]; (b) rigid connected squares model [12]; (c) rigid linear pentamer
model [13]; (d) rigid linear chain model [14,15]; (e) coarse-grained model with two hinges [17]; (f)
rigid linear chain model with two side arms and different φ angles [16]; (g) coarse-grained model from
crystal structure, either completely rigid (this work [20]) or somewhat flexible [19]; and (h) atomistic
model from crystal structure [17].
We found that the main body of fibrinogen protrudes more into solution the larger the curvature
of the surface. The fibrinogen main body is anchored to the surface by one of its D domains in the
same way regardless of the curvature, thus the effect on the protein orientation seems to be solely a
function of the curvature. Our model included only electrostatic interactions (and excluded volume),
but the results are still similar to those of Lopez and Lobaskin, who studied fibrinogen adsorption onto
hydrophobic surfaces [20].
It has been suggested that fibrinogen may adsorb to negatively charged surfaces by means of
electrostatic interactions between the net positively charged αC-domains and the surface [21–24].
However, in our present study, the αC-chain was found to have a net negative charge. This difference
is likely to be due to the treatment of the histidines. While we treated them as having zero charge,
Doolittle et al., for example, used a histidine pKa of 6.7 to calculate the charge of the Aα-chain at pH
7.3, giving a non-negligible charge on the histidines [25].) Our comparison of the free energies of
adsorption of the main body and the disordered fragments reveals that there is a stronger attraction
between one disordered fragment and the surface than between the fibrinogen main body and the
surface.
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2. Materials and Methods
2.1. Coarse-Grained Model
The main body of fibrinogen was modeled as a rigid molecule with a structure equal to the crystal
structure of human fibrinogen [8]. There is a slight difference between the two molecules that form the
asymmetric unit of the structure, and in this study biological assembly 1 was chosen. Each amino acid
was modeled as a sphere with a radius of 2.5 Å. This radius gives the sphere a smaller volume than
that of most amino acid residues but a more realistic contact separation between charges, which were
modeled as point charges located in the centers of the spheres. The pH was set to 7.4. Therefore, the
aspartic acid and glutamic acid residues were fully deprotonated (charge −1) while the lysine and
arginine residues were fully protonated (charge +1). The crystal structure also contained four bound
calcium ions with a charge of +2 each. The N- and C-terminals were modeled as separate spheres with
charges of +1 and −1, respectively. The number of charged histidine residues was estimated to be
negligible. All of the positions of the spheres were fixed relative to each other. The synthetic peptides
that were present when growing the crystals to determine the crystal structure were not included in
our protein model. Since the C-terminal parts of the α-chains were not included in the crystal structure,
the charges of the C-terminals of the parts of the α-chains present in the crystal structure were set
to zero.
Since some parts of fibrinogen are flexible, most notably the αC-chains, 35% of the amino acid
residues were not visible in the electron density maps, and thus they are not part of the crystal structure
determined by Kollman et al. [8]. To determine the role of the αC-chains for adsorption we studied an
αC-chain (residues 201–610 of the Aα-chain were here counted as the αC-chain since they were not
part of the crystal structure) separately using a coarse-grained model that has been used previously for
flexible proteins [26–30], with the exception that here the spheres representing amino acids are hard
instead of soft. In the present study, the electrostatic interactions were described using Debye–Hückel
theory, taking particle size into account using the following expression for the potential energy:
wij =

e2
4piε0εr
zizj
rij(1+κσij)
e−κ(rij−σij), rij ≥ σij
∞, rij < σij
(1)
where e is the elementary charge, ε0 is the vacuum permittivity, εr = 78.5 is the relative permittivity of
the solvent, rij is the distance between the centers of particles i and j, zi is the charge number of i, and
σij is the distance between the centers of particles i and j at contact. The Debye screening length (κ−1)
is calculated from the following equation:
κ−1 =
√
ε0εrkBT
2× 103NAe2 I (2)
where kB is Boltzmann’s constant, T is the temperature, NA is Avogadro’s constant and I is the ionic
strength of the solution.
The radius of the amino acid spheres was set to 2.0 Å to allow for realistic distances between
bonded residues. Bonded amino acids are connected with a harmonic potential:
wb = kh
(
Rb − Req
)2 (3)
where kh = 0.76kBT/Å2 is the spring constant, Rb is the bond length between the centers of the spheres,
and Req = 4.1 Å is the equilibrium distance of the harmonic potential measured between the centers
of the spheres. Non-bonded spheres also interact via a Lennard–Jones potential:
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wLJ = 4εnb
(σij
rij
)12
−
(
σij
rij
)6 (4)
where εnb = 0.05kBT is the interaction strength. The smooth surface was modeled as completely flat
with a smeared charge distribution. The electrostatic interactions between the charged amino acids
and the surface were modeled using Gouy–Chapman theory for a 1:1 salt:
wGC = 2zikBT ln
(
1 + Γ0e−κrs,i
1− Γ0e−κrs,i
)
, (5)
Γ0 = tanh
[
1
2
sinh−1
(
ρ√
8kBTc0ε0εr
)]
(6)
where rs,i is the distance between the surface and the center of amino acid i, ρ is the surface charge
density, and c0 is the concentration of 1:1 salt. The concentration of 1:1 salt was set to 0.025 M.
The idea was to compare with the silica surfaces used in the experiments made by Hulander
et al. [7], both with and without adsorbed silica nanoparticles. The surfaces were hydrophilic and
therefore no hydrophobic attraction between the protein and the surface was included. The charges of
the adsorbed nanoparticles were calculated to give the same surface charge density as that of the flat
surface and the charges were placed in the centers of the spheres. Adsorption to free nanoparticles
was also studied. The nanoparticles interacted with the amino acid beads according to Equation (1).
The z-axis constituted the normal to the surface and the boundaries of the simulation box were periodic
in the xy-directions. The side lengths of the simulation box varied between 150 and 420 nm depending
on the system.
2.2. Method
The simulations were performed using the Metropolis Monte Carlo algorithm [31] in the NVT
ensemble. The software used for the simulations was Faunus, a framework for Metropolis Monte
Carlo simulations [32]. For the simulations of the main body of fibrinogen, two types of moves were
used: translation and rotation of the fibrinogen entity. For the simulations of the αC-chains crankshaft
moves (pick two beads randomly and define the vector connecting them as the rotation axis, and then
rotate the beads between the picked ones around this axis), pivot moves (define a rotation axis in the
same manner as with the crankshaft move, and then rotate the beads at one end of the protein around
this axis) and single bead translation were also included.
2.3. Analysis
The angle between the protein main body and the surface of a nanoparticle was found in the
following way: a line was drawn between the middle of the protein main body and the middle of the
nanoparticle. Then, the cosine of the angle between this line and the protein was recorded.
The radius of gyration (Rg) of the αC-chain was found using the following equation:
R2g =
1
Mw
N
∑
i=1
mi × (ri − rcm)2, (7)
where Mw is the molecular weight of the αC-chain, mi is the mass of amino acid bead i, N is the
number of beads, ri is the coordinates of bead i, and rcm is the coordinates of the chain center-of-mass.
Biomolecules 2020, 10, 413 6 of 19
3. Results and Discussion
3.1. Characterization of Fibrinogen
The net charge of the main body of fibrinogen present in the crystal structure is −8 (counting also
the bound calcium ions). When including the flexible parts of the Aα-chains that are not visible in
the crystal structure, the net charge becomes −12. Figure 2b shows how the charges are distributed
over twenty bins in the longitudinal direction of the fibrinogen crystal structure. While the ends and
the middle of the protein are net negatively charged, there are also parts of the protein that are net
positively charged. These are potentially important for the ability of fibrinogen to adsorb to negatively
charged surfaces.
(a)
(b) (c) (d)
Figure 2. (a) An image of the coarse-grained fibrinogen body from the crystal structure. The red amino
acid residues are negatively charged, the blue residues are positively charged, and grey represents
neutral residues. (b) The charge distribution in the longitudinal direction of the fibrinogen crystal
structure. (c) The distribution of hydrophobic amino acid residues in the longitudinal direction of the
fibrinogen crystal structure. (d) The proportion of the ≥20% solvent-accessible amino acid residues
that are hydrophobic for each bin.
In addition to the charge distribution, the distribution of hydrophobic amino acids on the surface
of the protein could also be important for adsorption. Therefore, we studied how the hydrophobic
amino acid residues (Ala, Gly, Ile, Leu, Met, Phe, Pro, and Val) are distributed over the protein.
Figure 2c shows how the hydrophobic amino acid residues are distributed over the crystal structure
of fibrinogen. As expected, there is a clear correlation between the thickness of the protein and the
number of hydrophobic amino acid residues (cf. Figure 2a).
Figure 2d displays the proportion of the surface-accessible residues that are hydrophobic for
20 bins in the longitudinal direction of the fibrinogen crystal structure. The solvent-accessible
residues were found using Swiss PDB viewer [33], and the threshold for counting the residue as
solvent-accessible was set to ≥20% solvent accessibility. The results show that the ends of the protein
have a surface that is somewhat more hydrophobic than the rest of the protein.
3.2. Adsorption Simulations of the Main Body of Fibrinogen
In the simulations, we studied how different surface charges (density and sign), as well as
the presence of charged spherical nanoparticles on the flat surface, affect adsorption of fibrinogen.
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We also compared adsorption onto nanoparticles with different size and different spacing on the flat
surface. The aim was mainly to explain the finding that adsorbed fibrinogen increases the amount of
S. epidermidis that adheres to a flat surface, while the presence of adsorbed fibrinogen has the opposite
effect when nanoparticles are attached to the flat surface [7].
3.2.1. Adsorption onto a Flat Surface
The surface charge densities used were ±0.001e /Å2, ±0.005e/Å2, and ±0.01e/Å2. Mainly
the negatively charged surfaces were investigated. A realistic surface charge density for silica at
pH 7.4 and ionic strength 0.025 M would be approximately −0.001e/Å2 according to experimental
measurements [34,35]. However, according to simulation results, a realistic surface charge density is
−0.005e/Å2 (see the Supplementary Materials).
Figure 3a shows that, for both positive and negative surface charges, the fibrinogen body adsorbs
solely due to electrostatic forces if the surface charge is high enough. It seems that different orientations
of the protein are preferred depending on the sign of the surface charge, with the protein being
more inclined to stand up at the surface if the charge is positive (the mass center of the protein is
approximately half of a fibrinogen length away from the surface at one of the two free energy minima).
This is also illustrated in Figure 3b, showing the distribution of the cosine of the angles between
the adsorbed proteins and the surface normal for the highest surface charge densities. A value of 0
corresponds to the protein lying flat on the surface and a value of 1 to the protein standing up with its
axis completely parallel to the normal of the surface. When the surface charge is positive, it is strongly
favored that an adsorbed protein lies flat against the surface, although there is also a small maximum
at a cosine of ∼0.9, which is completely absent when the surface charge is negative.
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(c)
(d)
Figure 3. (a) The adsorption free energies for the fibrinogen main body to surfaces with different
surface charge densities. (b) Distribution of cosine of the angle between the surface normal and an
adsorbed protein for the higher surface charge densities. (The upper limit of the y-axis has been set so
that it is possible to view peaks other than the ones for small cosine.) (c) A configuration with cosine
close to 0, corresponding to the deepest free energy well when the surface charge is 0.01e/Å2. (d) A
configuration with high cosine, corresponding to the second free energy well when the surface charge
is 0.01e/Å2.
The fact that the fibrinogen main body adsorbs to both positively and negatively charged surfaces,
if they are charged enough, emphasizes the importance of local electrostatic interactions between
different charged groups in the protein and at the surface. However, since no adsorption is observed at
the experimentally determined surface charge of approximately −0.001e/Å2 (see Figure 3), something
is clearly missing in the model. It is probable that the experimental methods do not yield the surface
charge exactly at the surface. Kubiak et al. calculated a surface charge density by using Gouy–Chapman
theory to convert ζ-potential to charge density [24]. Even though the charge of the slipping plane
(where the ζ-potential is measured) should probably be considerably lower than the surface charge,
they found the same charge magnitude as those measured by Bolt [34] and Samoshina et al. [35].
Therefore, the surface charge of −0.005e/Å2 determined by simulations (see the Supplementary
Materials) may be more reliable.
It might also be the case that other attractive forces need to be included in the simulations in order
for them to match experiments. These could represent van der Waals forces or hydrogen bonding
between the surface and the protein. In addition, electrostatic attraction tends to increase when having
explicit surface charges and explicit ions in the solvent, which we did not have. Another possibility is
that the repulsion is overestimated since the amino acids are treated as hard spheres.
3.2.2. Adsorption Onto a Surface with Attached Nanoparticles
Table 1 shows a comparison between the adsorbed fractions of fibrinogen on the flat surfaces
and the surfaces with attached nanoparticles. The nanoparticles had a radius of 20 nm and the
surface coverage was 40%. The nanoparticles were hexagonally packed. The simulations show
that fibrinogen adsorbs more often on the nanostructured surfaces than on the flat surfaces in the
simulations, in agreement with previous QCM-D measurements [7].
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Table 1. The proportions of the fibrinogen main body that are adsorbed in simulations with flat and
nanostructured surfaces.
Surface Type Charge Density (e/Å2) Adsorbed Proportion (%)
Flat −0.001 0.503
Nanostructured −0.001 2.17
Flat −0.005 7.88
Nanostructured −0.005 100
Flat −0.01 39.2
Nanostructured −0.01 100
The fact that adsorption is higher on nanostructured surfaces is partly due to the fact that they
have a larger available surface area due to the added nanoparticles. However, Rechendorff et al., who
studied adsorption of fibrinogen onto surfaces with different degrees of roughness, found that the
adsorbed amount of fibrinogen increased more with roughness than the available surface area did [36].
Using Monte Carlo simulations, they found that fibrinogen is likely to adsorb to a higher degree
with an end-on orientation on the rough surfaces, increasing the number of fibrinogen molecules that
can bind.
Another reason for the increase in adsorption could be that the total charge of the nanoparticles
and the flat surface is larger than that of the flat surface alone, which should increase the adsorption
according to Figure 3a.
Figure 4a shows the distributions of cosine of the angle between a nanoparticle and an adsorbed
fibrinogen and between the flat surface and an adsorbed fibrinogen when the surface charge density
is −0.005e/Å2. On the flat surface, fibrinogen prefers to adsorb with the whole main body close to
the surface, while on the nanoparticles it protrudes further out in the solution. Figure 4b,c shows two
preferred orientations of fibrinogen adsorbed on the two types of surfaces.
It appears that one of the D domains adsorbs close to the surface, and that the angle between the
D domain and the rest of the fibrinogen rod, combined with the surface curvature, determines the
angle between the entire fibrinogen main body and the surface.
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(b)
(c)
Figure 4. (a) The distributions of cosine of the angle between fibrinogen and the normal to the surface
it is adsorbed to for two cases: when adsorbed to a nanoparticle attached to a flat surface and when
adsorbed to a flat surface without nanoparticles. The surface charge density is −0.005e/Å2. (b) A
typical orientation of fibrinogen adsorbed on the flat surface. (c) A typical orientation of fibrinogen
adsorbed on a nanoparticle.
3.2.3. Adsorption Onto Nanoparticles with Different Size
The results show that fibrinogen adsorbs more strongly to small nanoparticles (see Figure 5), and
more fibrinogen adsorbs to smaller nanoparticles per surface area (see Table 2). (Since essentially all
protein adsorbs for the higher surface charges, only results from the lowest charge are shown here
and in corresponding tables). However, while more fibrinogen adsorbs to small nanoparticles than
larger ones per surface area, less fibrinogen adsorbs to the small nanoparticles than the larger ones if
comparing adsorbed amount per nanoparticle (see Table 2).
The fact that less fibrinogen adsorbs to the small nanoparticles than the larger ones, if comparing the
adsorbed amount per nanoparticle, is of course due to the larger surface area of the larger nanoparticles.
This result is in agreement with the results of Lundqvist et al., showing a larger protein adsorption on
larger nanoparticles for a constant nanoparticle concentration [37]. However, Lundqvist et al. could
not determine whether this was due to the difference in curvature of the particles or the difference in
available surface area between the samples.
The explanation for the observation that fibrinogen binds more strongly to smaller nanoparticles
may lie in the fact that the ends of the rigid part of the fibrinogen molecule are approximately neutral
(see Figure 2b), with several positive charges available for favorable interaction with the surface, while
the middle of the molecule is negatively charged. Thus, if the positive charges at one end of the protein
bind to the negative surface in the same way regardless of the surface curvature, the adsorption is more
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favorable the further away from the surface that the negatively charged middle part of the protein
ends up.
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Figure 5. The radial distribution function g(r) between the surface of the nanoparticle and the mass
center of the main body of fibrinogen for different nanoparticle radii and surface charge densities:
(a) −0.001e/Å2; (b) −0.005e/Å2; and (c) −0.01e/Å2. The g(r) are normalized using the (constant)
concentration of fibrinogen in the simulation box instead of a bulk concentration for each simulation,
since reliable bulk concentrations could not be determined from the simulations with highest attraction
to the surface.
Table 2. The adsorbed proportion of the fibrinogen main body per surface area in simulations with a
single nanoparticle with different radii when the surface charge density is −0.001e/Å2.
Nanoparticle Radius (nm) Adsorbed Proportion (%) Adsorbed Proportion/Surface Area (10−6 nm−2)
10 0.179 3.78
20 0.474 1.64
30 0.825 0.729
40 1.27 0.628
The angle between the adsorbed fibrinogen molecule and the surface of the nanoparticle increases
as the size of the nanoparticle decreases (see Figure 6). This is due to the fact that fibrinogen adsorbs
with one of its ends on the surface of the particle in a similar way regardless of the nanoparticle size,
and the higher is the curvature of the particle, the larger is the angle. Similar results were obtained by
Lopez and Lobaskin for fibrinogen adsorption onto hydrophobic nanoparticles [20].
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Figure 6. The distribution of cosine of the angle between the surface normal and the adsorbed
fibrinogen main body for different nanoparticle radii when the surface charge density is:
(a) −0.001e/Å2; and (b) −0.005e/Å2.
3.2.4. Adsorption Onto Nanostructured Surfaces with Different Nanoparticle Size
Here, adsorption of the fibrinogen main body onto surfaces with attached nanoparticles of
different sizes are compared. Firstly, the number density of nanoparticles on the surface is held
constant (distance between centers of nearest neighbors = 60 nm) and, secondly, the surface coverage
of the nanoparticles is constant (40%). The nanoparticle radii are 10, 20, and 30 nm. On all surfaces
studied here, the nanoparticles were packed hexagonally. When the nanoparticle number density is
constant, the adsorbed fraction of fibrinogen is highest for a nanoparticle radius of 20 nm (see the second
column of Table 3). When the nanoparticle radius is increased from 10 to 20 nm, the available surface
area increases since the nanoparticles become larger and thus contribute with more surface area.
However, when the nanoparticle radius is further increased to 30 nm, the spheres are in contact with
each other and thus the available surface area decreases. Thus, in this case, the nanoparticles with
20 nm radius give maximum adsorption since they give the largest available surface area.
Table 3. The adsorbed proportion of the fibrinogen main body in simulations with flat surfaces with
attached nanoparticles with different radii for a fixed distance between centers of nearest neighbors
(nn) and a fixed surface coverage of nanoparticles (sc). The surface charge density for the flat surface
and the nanoparticles is −0.001e/Å2.
Nanoparticle Radius (nm) Adsorbed Proportion (%), nn = 60 nm Adsorbed Proportion (%), sc = 40%
10 1.05 1.50
20 2.17 2.17
30 1.46 2.73
When the nanoparticle surface coverage is constant at 40%, the adsorbed fraction increases with
nanoparticle size for all sizes used, see the third column of Table 3. Here, the total surface area of
the spheres is the same for all three nanoparticle radii. Thus, it could be expected from the results of
the simulations with single nanoparticles that more fibrinogen would adsorb onto the surface with
small nanoparticles. However, when the small nanoparticles are attached to a flat surface, a larger
proportion of the surface area of each sphere is blocked by the flat surface than for the larger spheres.
This makes the surface area that is available for fibrinogen adsorption smaller for surfaces with smaller
attached nanoparticles.
3.2.5. Adsorption Onto Nanostructured Surfaces with Different Nanoparticle Spacing
Simulations with nanostructured surfaces with nanoparticles of 20 nm radius were performed for
different spacings between the nanoparticles. The center-to-center distance between nearest neighbors
was varied between 40 and 90 nm in steps of 10 nm. The adsorbed fractions are shown in Figure 7.
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Figure 7. The adsorbed proportion of the fibrinogen main body in simulations with flat surfaces with
attached nanoparticles (20 nm radius) with different distances between centers of nearest neighbors.
The surface charge density for the flat surface and the nanoparticles is −0.001e/Å2.
The adsorbed amount onto a surface with attached nanoparticles with a radius of 20 nm increases
when the nearest neighbor center-to-center distance increases from 40 to 60 nm. This is due to the
fact that, when the nanoparticles are close to each other, it is difficult or impossible for the protein to
adsorb between the nanoparticles. However, for 60 nm spacing, the available surface area is large. As
the spacing increases even more, the nanoparticles become fewer, thus reducing the available surface
area and the adsorbed amount.
3.3. Simulations of the αC-Chain of Fibrinogen
3.3.1. Simulations in Bulk and with a Flat Surface
The charges of the αC-chain are relatively evenly distributed over the molecule (see Figure 8a).
However, some parts of the chain are net positively charged, possibly contributing to the adsorption of
the chain on a negatively charged surface. Figure 8d shows that the αC-chain adsorbs electrostatically
to surfaces with charge densities of −0.005 e/Å2 and −0.01 e/Å2, as the main body of fibrinogen
did. However, the free energy minima for the αC-chain is lower than for the fibrinogen main body
(Figure 3a). Figure 8b shows the distribution of the radius of gyration of the αC-chain in bulk and
Figure 8c shows the distribution of the shape factor, R2ee/R2g, where Ree is the end-to-end distance and
Rg is the radius of gyration. A shape factor of 6 is characteristic of a Gaussian chain and a shape factor
of 12 corresponds to a rigid rod. Thus, the αC-chain behaves as a Gaussian chain in the simulations.
A comparison between the free energies in Figures 3 and 8 shows that the αC-chains are important
for the adsorption of the complete fibrinogen since the free energy minimum is lower than for the
fibrinogen main body.
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Figure 8. (a) The distribution of charges of the αC-chain divided into 41 bins (10 amino acid residues
per bin) starting from the N-terminal. The negative charge of the C-terminal is included. (b) The
distribution of the radius of gyration of the αC-chain in bulk. (c) The distribution of the shape factor
of the αC-chain in bulk. (d) The adsorption free energies for the αC-chain to surfaces with different
negative surface charge densities.
3.3.2. Adsorption Onto Different Types of Surfaces
Table 4 shows the proportions of the αC-chain that adsorbs to a flat and a nanostructured surface,
respectively, in the simulations. The nanostructured surface is the same as in Section 3.2.2. The trends
are the same as for the main body of fibrinogen (Table 1) but the adsorbed amounts of the αC-chain are
higher, again showing the importance of the αC-chains for the overall adsorption.
Table 4. The proportions of the fibrinogen αC-chain that are adsorbed in simulations with flat and
nanostructured surfaces.
Surface Type Charge Density (e/Å2) Adsorbed Proportion (%)
Flat −0.001 1.23
Nanostructured −0.001 3.14
Flat −0.005 60.1
Nanostructured −0.005 100
Flat −0.01 100
Nanostructured −0.01 100
3.3.3. Adsorption Onto Nanoparticles with Different Size
From g(r) in Figure 9a, no significant difference can be observed between the adsorption of the
αC-chain of fibrinogen onto nanoparticles with radii of 10, 20, 30, and 40 nm when the surface charge
density is −0.001e/Å2. However, when the surface charge density is −0.01e/Å2, the αC-chain adsorbs
more strongly to the smallest nanoparticle (radius 10 nm) (see Figure 9b).
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Figure 9. The radial distribution function g(r) between the surface of the nanoparticle and the mass
center of the αC-chain for different nanoparticle radii and surface charge densities: (a) −0.001e/Å2;
(b) −0.005e/Å2; and (c) −0.01e/Å2. The g(r) are normalized using the (constant) concentration of the
αC-chain in the simulation box instead of a bulk concentration for each simulation, since reliable bulk
concentrations could not be determined from the simulations with highest attraction to the surface.
Table 5, however, shows that more of the αC-chain adsorbs on the smaller nanoparticles (radii 10
and 20 nm) per surface area also for the lower surface charge density of −0.001e/Å2.
Table 5. The adsorbed proportion of the αC-chain of fibrinogen per surface area in simulations with a
single nanoparticle with different radii when the surface charge density is −0.001e/Å2.
Nanoparticle Radius (nm) Adsorbed Proportion (%) Adsorbed Proportion/Surface Area (10−6 nm−2)
10 0.128 1.02
20 0.392 0.781
30 0.774 0.684
40 1.38 0.687
The trends here are the same as for the main body of fibrinogen. The reason could be that, due to
the smaller surface area of the 10-nm nanoparticles, negative amino acid residues on an adsorbed
protein that are further away from the surface do not feel as much repulsion as they would in the same
conformation adsorbed on a larger nanoparticle.
3.3.4. Adsorption Onto Nanostructured Surfaces with Different Nanoparticle Size
Here, the results from adsorption simulations of the αC-chain onto the same nanostructured
surfaces as studied for the fibrinogen main body (Section 3.2.4) is presented. The trends for the
adsorbed fractions are the same as for the fibrinogen main body (cf. Tables 3 and 6). The reason is the
same as described previously—the trends follow the available surface area.
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Table 6. The adsorbed proportion of the fibrinogen αC-chain in simulations with flat surfaces with
attached nanoparticles with different radii for a fixed distance between centers of nearest neighbors
(nn) and a fixed surface coverage of nanoparticles (sc). The surface charge density for the flat surface
and the nanoparticles is −0.001e/Å2.
Nanoparticle Radius (nm) Adsorbed Proportion (%), nn = 60 nm Adsorbed Proportion (%), sc = 40%
10 1.54 1.69
20 3.15 3.15
30 1.95 3.34
3.3.5. Adsorption Onto Nanostructured Surfaces with Different Nanoparticle Spacing
Here, results from simulations with nanostructured surfaces with nanoparticles of 20 nm radius
and different spacings are presented. The adsorbed fractions are shown in Figure 10. The trends are the
same as for the fibrinogen main body, with the highest adsorbed amount when the distance between
the centers of neighboring particles is 60 nm. Here, the optimal combination of available surface area
between the particles and available surface area on the particles is found.
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Figure 10. The adsorbed proportion of the fibrinogen αC-chain in simulations with flat surfaces with
attached nanoparticles (20 nm radius) with different distances between centers of nearest neighbors.
The surface charge density for the flat surface and the nanoparticles is −0.001e/Å2.
4. Conclusions
We used coarse-grained simulations to study the adsorption of the fibrinogen main body, as well
as the fibrinogen αC-chain, on negatively charged smooth surfaces, nanospheres, and flat surfaces
with attached nanospheres.
Our study confirms that the disordered αC-chains of fibrinogen are important for adsorption on
negatively charged surfaces. A single αC-chain attaches more firmly than the fibrinogen main body.
When fibrinogen adsorbs to surfaces with attached nanospheres, the available surface area is generally
what determines the proportion of fibrinogen that is adsorbed. However, when the different parts of
the fibrinogen molecule are adsorbed to spherical nanoparticles in solution, the adsorbed amount per
surface area increases as the size of the nanoparticle decreases. The reason could be that that negatively
charged amino acid residues feel less repulsion from the negatively charged nanoparticle the smaller it
is, since the surface area is smaller.
We found that the main body of fibrinogen protrudes more into solution as the curvature of the
surface increases, and that the main body of fibrinogen is anchored to the surface through one of is
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D-domains. This was found true regardless of the surface curvature and the orientation therefore
seems to be solely a function of the surface curvature. Thus, we hypothesize that fibrinogen adsorbed
on surfaces with attached nanoparticles makes cell-binding epitopes less available to attaching cells.
This could explain previous findings where the adhesion of S. epidermidis was hampered on fibrinogen
adsorbed to nanostructured compared to smooth substrates.
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